Ptc Therapeutics (PTCT) Other Non Operating Income (2012 - 2026)

Ptc Therapeutics' Other Non Operating Income history runs 15 years deep, the most recent figure standing at -$3.0 million for Q2 2026.

• In Q2 2026, Other Non Operating Income rose 48.56% year-over-year to -$3.0 million; the TTM figure through Jun 2026 stood at $53.3 million (up 1153.06% YoY), while the FY2025 annual figure was $42.6 million, up 551.39% from the prior year.
• Other Non Operating Income for Q2 2026 stood at -$3.0 million, down from $1.6 million in the prior quarter.
• The five-year high for Other Non Operating Income was $48.2 million in Q4 2025, with the low at -$128.7 million in Q4 2023.
• The 5-year median for Other Non Operating Income is -$1.9 million (2024), against an average of -$7.7 million.
• The sharpest annual moves came in 2022 and 2025: Other Non Operating Income plunged 1183.82% in 2022, then surged 447.33% in 2025.
• Ptc Therapeutics' Other Non Operating Income stood at $35.1 million in 2022, then sank by 466.24% to -$128.7 million in 2023, then jumped by 106.88% to $8.8 million in 2024, then soared by 444.26% to $48.2 million in 2025, then slumped by 106.13% to -$3.0 million in 2026.
• Business Quant data shows PTCT's Other Non Operating Income at -$3.0 million in Q2 2026, $1.6 million in Q1 2026, and $48.2 million in Q4 2025.